Pharmaceutical

Diffusion Pharma’s stockholders support merger with EIP Pharma

The merger will be finalised today, transforming the businesses into a single company CervoMed focused on neurodegenerative diseases.

Aug 16, 2023 - 20:00
Diffusion Pharma’s stockholders support merger with EIP Pharma
The merger will be finalised today, transforming the businesses into a single company CervoMed focused on neurodegenerative diseases.
Read the original article

Tags:

Previous Article

FDA will not meet ahead of bluebird bio’s sickle cell disease gene therapy PDUFA...

Next Article

Eyenovia acquires US licencing rights for Formosa’s topical eye steroid

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Cancer Research UK and CRIS fund lung cancer vaccine research

Cancer Research UK and CRIS fund lung cancer vaccine re...

Mar 26, 2024

Listen: The FTC v. Amgen, Sarepta’s future, & Galapagos’ turnaround

Listen: The FTC v. Amgen, Sarepta’s future, & Galapagos...

May 19, 2023

Hasten Biopharmaceutic raises $315m for pipeline assets development

Hasten Biopharmaceutic raises $315m for pipeline assets...

Apr 20, 2023